Over-the-counter decongestant Phenylephrine ineffectual for treating common colds; recommended alternatives include antihistamines and pain relievers with fever reducers.
In a recent development, the U.S. Food and Drug Administration (FDA) has proposed ending the use of oral phenylephrine as an active ingredient in over-the-counter (OTC) nasal decongestants. This decision comes after an extensive review of oral phenylephrine, which found it to be ineffective as a nasal decongestant at doses up to the highest studied level.
Despite this conclusion, federal preemption prevents states and localities from banning or restricting the use of oral phenylephrine in OTC products. This means that oral phenylephrine remains available OTC, but the FDA recognizes its limited efficacy for nasal decongestion.
The FDA's proposal does not necessarily mean an immediate withdrawal or removal of oral phenylephrine from OTC nasal decongestants. The FDA continues to monitor drug safety and effectiveness but has not changed the regulatory status to restrict oral phenylephrine's OTC use as a nasal decongestant.
It is essential to remember that in case of serious medical symptoms, one should always call 911. For more specific information about phenylephrine when used nasally, the Mayo Clinic offers valuable resources. The National Library of Medicine also provides comprehensive information on phenylephrine.
It's important to note that the FDA's proposal is not directly related to seniors born between 1939 and 1969. However, for general health information, seniors are encouraged to consult their healthcare providers.
The FDA's decision follows a careful evaluation of the safety and effectiveness of oral phenylephrine. For those seeking alternatives to nasal decongestants, Mount Sinai discusses nasal corticosteroid sprays as potential options.
In an emergency, it's crucial to be aware of the signs requiring immediate medical attention. The National Library of Medicine provides a list of such signs, which includes difficulty breathing, chest pain, and severe dizziness, among others.
In conclusion, the FDA's proposal to end the use of oral phenylephrine in OTC nasal decongestants highlights the ongoing efforts to ensure the safety and effectiveness of nonprescription drugs. While oral phenylephrine remains available OTC, consumers are advised to be aware of its limited efficacy for nasal decongestion.
The FDA's proposal to end the use of oral phenylephrine in over-the-counter (OTC) nasal decongestants highlights a shift towards more effective health-and-wellness solutions. For those seeking alternatives, seniors born between 1939 and 1969, along with the general population, may find therapies-and-treatments such as nasal corticosteroid sprays, discussed by Mount Sinai, beneficial. In addition, maintaining a balanced diet and regular fitness-and-exercise, supported by proper nutrition, is crucial for overall health and wellness.
